EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C18H28N2O |
| Net Charge | 0 |
| Average Mass | 288.435 |
| Monoisotopic Mass | 288.22016 |
| SMILES | CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C |
| InChI | InChI=1S/C18H28N2O/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21)/t16-/m0/s1 |
| InChIKey | LEBVLXFERQHONN-INIZCTEOSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Roles: | amphiphile A surfactant molecule possessing both hydrophilic and lipophilic properties. Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor An EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor that interferes with the action of Ca2+-transporting ATPase (EC 3.6.3.8). analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. EC 3.1.1.8 (cholinesterase) inhibitor An EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of cholinesterase (EC 3.1.1.8). adrenergic antagonist An agent that binds to but does not activate adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. |
| Applications: | local anaesthetic Any member of a group of drugs that reversibly inhibit the propagation of signals along nerves. Wide variations in potency, stability, toxicity, water-solubility and duration of action determine the route used for administration, e.g. topical, intravenous, epidural or spinal block. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. adrenergic antagonist An agent that binds to but does not activate adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| levobupivacaine (CHEBI:6149) has role adrenergic antagonist (CHEBI:37887) |
| levobupivacaine (CHEBI:6149) has role amphiphile (CHEBI:59941) |
| levobupivacaine (CHEBI:6149) has role analgesic (CHEBI:35480) |
| levobupivacaine (CHEBI:6149) has role antineoplastic agent (CHEBI:35610) |
| levobupivacaine (CHEBI:6149) has role EC 3.1.1.8 (cholinesterase) inhibitor (CHEBI:37733) |
| levobupivacaine (CHEBI:6149) has role EC 3.6.3.8 (Ca2+-transporting ATPase) inhibitor (CHEBI:60186) |
| levobupivacaine (CHEBI:6149) has role local anaesthetic (CHEBI:36333) |
| levobupivacaine (CHEBI:6149) is a 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide (CHEBI:77431) |
| levobupivacaine (CHEBI:6149) is conjugate base of levobupivacaine(1+) (CHEBI:77458) |
| levobupivacaine (CHEBI:6149) is enantiomer of dextrobupivacaine (CHEBI:60790) |
| Incoming Relation(s) |
| bupivacaine (CHEBI:3215) has part levobupivacaine (CHEBI:6149) |
| levobupivacaine(1+) (CHEBI:77458) is conjugate acid of levobupivacaine (CHEBI:6149) |
| dextrobupivacaine (CHEBI:60790) is enantiomer of levobupivacaine (CHEBI:6149) |
| IUPAC Name |
|---|
| (2S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide |
| INNs | Source |
|---|---|
| levobupivacaina | WHO MedNet |
| levobupivacaine | ChemIDplus |
| Synonyms | Source |
|---|---|
| (−)-bupivacaine | ChEBI |
| Bupivacaine, (-)- | ChEMBL |
| Bupivacaine (-)-form | ChEMBL |
| Bupivacaine, (s)- | ChEMBL |
| (S)-1-butyl-2',6'-pipecoloxylidide | ChemIDplus |
| (S)-bupivacaine | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| 4 | DrugCentral |
| C07887 | KEGG COMPOUND |
| D08116 | KEGG DRUG |
| DB01002 | DrugBank |
| HMDB0015137 | HMDB |
| Levobupivacaine | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| Reaxys:5382240 | Reaxys |
| CAS:27262-47-1 | KEGG COMPOUND |
| CAS:27262-47-1 | ChemIDplus |
| Citations |
|---|